These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23788719)

  • 1. Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales.
    Rosenkrantz AB; Kim S; Lim RP; Hindman N; Deng FM; Babb JS; Taneja SS
    Radiology; 2013 Nov; 269(2):482-92. PubMed ID: 23788719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of interreader reproducibility of the prostate imaging reporting and data system and likert scales for evaluation of multiparametric prostate MRI.
    Rosenkrantz AB; Lim RP; Haghighi M; Somberg MB; Babb JS; Taneja SS
    AJR Am J Roentgenol; 2013 Oct; 201(4):W612-8. PubMed ID: 24059400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Dominant Sequence Paradigm and Role of Dynamic Contrast-enhanced Imaging in PI-RADS Version 2.
    Greer MD; Shih JH; Lay N; Barrett T; Kayat Bittencourt L; Borofsky S; Kabakus IM; Law YM; Marko J; Shebel H; Mertan FV; Merino MJ; Wood BJ; Pinto PA; Summers RM; Choyke PL; Turkbey B
    Radiology; 2017 Dec; 285(3):859-869. PubMed ID: 28727501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.
    Hoeks CM; Hambrock T; Yakar D; Hulsbergen-van de Kaa CA; Feuth T; Witjes JA; Fütterer JJ; Barentsz JO
    Radiology; 2013 Jan; 266(1):207-17. PubMed ID: 23143029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate Imaging Reporting and Data System and Likert Scoring System: Multiparametric MR Imaging Validation Study to Screen Patients for Initial Biopsy.
    Renard-Penna R; Mozer P; Cornud F; Barry-Delongchamps N; Bruguière E; Portalez D; Malavaud B
    Radiology; 2015 May; 275(2):458-68. PubMed ID: 25599415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: Prostate Imaging Reporting and Data System Version 1 versus Version 2.
    Feng ZY; Wang L; Min XD; Wang SG; Wang GP; Cai J
    Chin Med J (Engl); 2016 Oct; 129(20):2451-2459. PubMed ID: 27748338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric MRI of the prostate: diagnostic performance and interreader agreement of two scoring systems.
    Lin WC; Muglia VF; Silva GE; Chodraui Filho S; Reis RB; Westphalen AC
    Br J Radiol; 2016 Jun; 89(1062):20151056. PubMed ID: 27007818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interobserver Reproducibility of the PI-RADS Version 2 Lexicon: A Multicenter Study of Six Experienced Prostate Radiologists.
    Rosenkrantz AB; Ginocchio LA; Cornfeld D; Froemming AT; Gupta RT; Turkbey B; Westphalen AC; Babb JS; Margolis DJ
    Radiology; 2016 Sep; 280(3):793-804. PubMed ID: 27035179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposed Adjustments to PI-RADS Version 2 Decision Rules: Impact on Prostate Cancer Detection.
    Rosenkrantz AB; Babb JS; Taneja SS; Ream JM
    Radiology; 2017 Apr; 283(1):119-129. PubMed ID: 27783538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interobserver Agreement and Positivity of PI-RADS Version 2 Among Radiologists with Different Levels of Experience.
    Mussi TC; Yamauchi FI; Tridente CF; Tachibana A; Tonso VM; Recchimuzzi DR; de Souza Leão LR; Luz DC; Martins T; Baroni RH
    Acad Radiol; 2019 Aug; 26(8):1017-1022. PubMed ID: 30268722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of observation size and apparent diffusion coefficient (ADC) value in PI-RADS v2.1 assessment category 4 and 5 observations compared to adverse pathological outcomes.
    Abreu-Gomez J; Walker D; Alotaibi T; McInnes MDF; Flood TA; Schieda N
    Eur Radiol; 2020 Aug; 30(8):4251-4261. PubMed ID: 32211965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate Cancer: The European Society of Urogenital Radiology Prostate Imaging Reporting and Data System Criteria for Predicting Extraprostatic Extension by Using 3-T Multiparametric MR Imaging.
    Kayat Bittencourt L; Litjens G; Hulsbergen-van de Kaa CA; Turkbey B; Gasparetto EL; Barentsz JO
    Radiology; 2015 Aug; 276(2):479-89. PubMed ID: 25848900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI-RADS Versions 2 and 2.1: Interobserver Agreement and Diagnostic Performance in Peripheral and Transition Zone Lesions Among Six Radiologists.
    Bhayana R; O'Shea A; Anderson MA; Bradley WR; Gottumukkala RV; Mojtahed A; Pierce TT; Harisinghani M
    AJR Am J Roentgenol; 2021 Jul; 217(1):141-151. PubMed ID: 32903060
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of Prostate Imaging Reporting and Data System versions 1 and 2 for the Detection of Peripheral Zone Gleason Score 3 + 4 = 7 Cancers.
    Krishna S; McInnes M; Lim C; Lim R; Hakim SW; Flood TA; Schieda N
    AJR Am J Roentgenol; 2017 Dec; 209(6):W365-W373. PubMed ID: 28981356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1.5-T multiparametric MRI using PI-RADS: a region by region analysis to localize the index-tumor of prostate cancer in patients undergoing prostatectomy.
    Reisæter LA; Fütterer JJ; Halvorsen OJ; Nygård Y; Biermann M; Andersen E; Gravdal K; Haukaas S; Monssen JA; Huisman HJ; Akslen LA; Beisland C; Rørvik J
    Acta Radiol; 2015 Apr; 56(4):500-11. PubMed ID: 24819231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Likert and PI-RADS version 2 MRI scoring systems for the detection of clinically significant prostate cancer.
    Zawaideh JP; Sala E; Pantelidou M; Shaida N; Koo B; Caglic I; Warren AY; Carmisciano L; Saeb-Parsy K; Gnanapragasam VJ; Kastner C; Barrett T
    Br J Radiol; 2020 Aug; 93(1112):20200298. PubMed ID: 32479105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of PI-RADS version 2 and PI-RADS version 2.1 for the detection of transition zone prostate cancer.
    Tamada T; Kido A; Takeuchi M; Yamamoto A; Miyaji Y; Kanomata N; Sone T
    Eur J Radiol; 2019 Dec; 121():108704. PubMed ID: 31669798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What Are We Missing? False-Negative Cancers at Multiparametric MR Imaging of the Prostate.
    Borofsky S; George AK; Gaur S; Bernardo M; Greer MD; Mertan FV; Taffel M; Moreno V; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    Radiology; 2018 Jan; 286(1):186-195. PubMed ID: 29053402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume.
    Mazaheri Y; Hricak H; Fine SW; Akin O; Shukla-Dave A; Ishill NM; Moskowitz CS; Grater JE; Reuter VE; Zakian KL; Touijer KA; Koutcher JA
    Radiology; 2009 Aug; 252(2):449-57. PubMed ID: 19703883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of PI-RADS v1 and v2 for multiparametric MRI detection of prostate cancer with whole-mount histological workup as reference standard.
    Schaudinn A; Gawlitza J; Mucha S; Linder N; Franz T; Horn LC; Kahn T; Busse H
    Eur J Radiol; 2019 Jul; 116():180-185. PubMed ID: 31153562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.